Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
British Journal of Clinical Pharmacology|March 15, 2011
In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotypeDinko Rekić, Daniel Röshammar, Jackson Mukonzo, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 12, 2013
Model based design and analysis of phase II HIV-1 trialsDinko Rekić, Daniel Röshammar, Ulrika S H SimonssonJournal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.International Journal of Clinical Pharmacology and Therapeutics|February 1, 2017
Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarctionDaniel Röshammar, Martin Bergstrand, Tomas Andersson, et al.CPT: Pharmacometrics & Systems Pharmacology|February 10, 2023
N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysisEmma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.Clinical and Translational Science|September 11, 2022
Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerationsEmma Eckernäs, Christopher Timmermann, Robin Carhart-Harris, et al.Drugs in R&D|March 23, 2016
Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending DosesTrine Høyer Rose, Daniel Röshammar, Lars Erichsen, et al.Drugs in R&D|May 4, 2016
Characterisation of Population Pharmacokinetics and Endogenous Follicle-Stimulating Hormone (FSH) Levels After Multiple Dosing of a Recombinant Human FSH (FE 999049) in Healthy WomenTrine Høyer Rose, Daniel Röshammar, Lars Erichsen, et al.European Journal of Clinical Pharmacology|March 30, 2006
Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjectsDaniel Röshammar, Trinh Ngoc Hai, Sofia Friberg Hietala, et al.Journal of Clinical Pharmacology|November 19, 2016
Exposure-Response Analyses Supporting Ticagrelor Dosing Recommendation in Patients With Prior Myocardial InfarctionDaniel Röshammar, Joakim Nyberg, Tomas Andersson, et al.Pageof 3